- Nevada announces $45M settlement with McKinsey over opioids (apnews.com)Nevada secures $45 million settlement in opioid litigation, accusing consulting firm of deceptive marketing practices that led to overdose deaths (thenevadaindependent.com)
Nevada has struck a $45 million settlement deal with McKinsey & Company for the global consulting firm’s role in advising opioid makers how to sell more prescription painkillers amid a national overdose crisis...The western state reached the deal after sitting out a multi-state settlement with McKinsey announced in February. The hard bargaining has allowed Nevada to win a settlement that’s three and a half times larger than the average settlement with other states...READ MORE
- Amazon to widen Amazon Care service availability (drugstorenews.com)'Game on': Competition in telehealth, primary care spaces heats up as Amazon Care expands, analysts say (fiercehealthcare.com)Lynch: CVS confident about strategy as Amazon aims to muscle in on its turf (fiercehealthcare.com)
Amazon is taking its health care offerings to new places. The company announced plans to roll out Amazon Care, its on-demand healthcare service across the United States this summer...The move follows the launch 18 months ago of Amazon Care to provide Amazon employees and their families immediate access to high-quality medical care...Amazon Care has two components. The first is virtual care, which connects patients to medical professionals via the Amazon Care app...The second component is in-person care, where Amazon Care can dispatch a medical professional to a patient’s home for additional care...READ MORE
- Why is FDA reopening a drug-naming study just 3 months after issuing new guidance? (fiercepharma.com)
Drug names often draw curiosity and confusion—and they always get a once-over by the FDA. The agency is more than usually interested these days, though...After a round of new guidance issued in December, the FDA is dipping back into the issue by reopening a proposed study to determine how drug names influence consumers and healthcare providers...Its December report “Best Practices in Developing Proprietary Names for Human Prescription Drug Products” includes suggestions for drugmakers and their naming agency partners to avoid misbranding violations...READ MORE
- Nevada pharmacies now vaccinating 55+ with health conditions (reviewjournal.com)
People from 55 to 64 with certain medical conditions are now eligible to get COVID-19 vaccinations at Nevada pharmacies, with no proof of medical status required...The state opened up eligibility this week to those in this age group with conditions ranging from cancer to smoking that put them at higher risk for serious disease from COVID-19...Eligibility also has been extended to those with conditions that only potentially put them at higher risk, such as asthma or dementia, as well as to those with disabilities or who are experiencing homelessness...READ MORE
- FDA warning letters detail violations at China, Mexico drugmakers already under import alert (fiercepharma.com)
Shoddy manufacturing practices triggered FDA warning letters for a pair of foreign producers of over-the-counter drugs...Dibar of Mexico, a CDMO for nutritional and self-care products, and Foshan Biours Biosciences of China, which specializes in gel patches, were cited for failure to fix problems the FDA raised in April of last year...The companies have been barred from importing their products to the U.S. since last fall...READ MORE
- U.S. to share 4 million doses of AstraZeneca COVID-19 vaccine with Mexico, Canada (reuters.com)
The United States plans to send roughly 4 million doses of AstraZeneca's COVID-19 vaccine that it is not using to Mexico and Canada in loan deals with the two countries, yielding to requests to share vaccines with allies...Mexico will receive 2.5 million doses of the vaccine and Canada is to receive 1.5 million doses...The Biden administration has come under pressure from countries around the world to share vaccines, particularly its stock of AstraZeneca’s vaccine, which is authorized for use elsewhere but not yet in the United States...READ MORE
- FTC joins overseas antitrust regulators in reexamination of pharma M&A (biopharmadive.com)
The U.S. Federal Trade Commission will join European, British and Canadian regulators, as well as with counterparts at the U.S. Justice Department and states attorneys general, to update their approach to reviewing pharmaceutical acquisitions, a move the commission's acting chair said was prompted by the "high volume of these mergers," increasing drug prices and other anti-competitive issues...Antitrust regulators watch drugmaker mergers closely to determine whether tie-ups could impede development of newer and potentially better medicines...READ MORE
- UNLV School of Medicine’s first graduating class has ‘Match Day’ (reviewjournal.com)Industry Voices—You've matched! Now what? 5 tips for future medical residents (fiercehealthcare.com)
Fourth-year students in the UNLV School of Medicine’s first graduating class participated Friday in Match Day to find out where they’ll do their residency...The school held a small outdoor ceremony at its Shadow Lane campus in central Las Vegas. Each student was allowed to invite one guest to the ceremony, which was streamed live online...At 9 a.m., each student opened a deck of playing cards and pulled out one saying where they’ll spend the next three to seven years doing a residency in their chosen specialty...Match Day happened Friday across the United States — and even internationally — for students to learn which U.S. residency program they’re matched with. Touro University Nevada in Henderson and University of Nevada, Reno, also held events...READ MORE
- Pfizer halts biosimilar programs in crowded China market, sells plant to WuXi Biologics (fiercepharma.com)
China only approved its first biosimilar drug in 2019, but the market is already looking too crowded for one Big Pharma company...Pfizer has halted its biosimilar programs in China and is selling a biologics facility there to Chinese CDMO giant WuXi Biologics...The “difficult decision” came after a “comprehensive review of the biosimilars market and the company’s global manufacturing network,” Pfizer said...READ MORE
- Overworked, understaffed: Pharmacists say industry is in crisis, putting patient safety at risk (msn.com)
From the moment Marilyn Jerominski walks into her pharmacy every morning, her time is in demand. As pharmacy manager of a busy 24-hour Walgreens in Palm Desert, California, she is responsible for the safety and accuracy of the thousands of prescriptions the store dispenses every week..."There's so much stress," Jerominski said. "You're not only running to the drive-thru but to the front, to the vaccination station to give a vaccination, then to the phone. ... It's almost impossible for any human to keep that momentum day in and out."...Jerominski is one of an estimated 155,000 pharmacists working at chain drugstores who, over the past decade, have found themselves pushed to do more with less. They're working faster, filling more orders and juggling a wider range of tasks with fewer staff members at a pace that many say is unsustainable and jeopardizes patient safety...READ MORE